Position in EWTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,420,340
+$1,669,571 QoQ
Shares Held
108,795
+24.6% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#70
of 223 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. EWTX ranks #11 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in EWTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,420,340 | 108,795 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $2,750,769 | 87,326 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,157,143 | 86,929 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $829,036 | 51,112 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $744,621 | 56,798 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,495,450 | 67,975 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $2,044,338 | 76,567 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,839,101 | 68,906 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,311,902 | 72,843 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,197,857 | 65,672 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $472,892 | 43,226 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $268,588 | 46,874 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $360,475 | 46,513 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $277,998 | 41,679 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $383,579 | 42,906 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||